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Introduction
As the burden of chronic diseases in the United States
continues to increase, greater efforts are being made to
identify and implement interventions that successfully
reduce disease risk, improve access to high-quality health
care, and create sustainable health-promotion programs
that ultimately improve health status and quality of life (1).
Identifying effective primary and secondary prevention
strategies through tailored program evaluation efforts has
become an essential public health function in clinical and
public health settings (2). Articles in this issue of Preventing
Chronic Disease (PCD) address various aspects of program
evaluation, such as planning, methods, approaches, stake-
holder involvement, and the use of program evaluation
findings to guide the direction of future programs.
The articles presented in this issue have three primary
goals: 1) to provide the reader with practical examples of
program evaluation that can be immediately applied in
other settings; 2) to carefully discuss the way program
missions and objectives, stakeholder interests, evaluation
theory, and evaluation methods are considered when con-
ducting, analyzing, and reporting the status of program
outcomes; and 3) to candidly explore the use of evaluation
frameworks, logic models, and organizational strategic plan-
ning to increase capacity for routinely monitoring program
outcomes at the national, state, and community levels.
Chronic Diseases in the United States
Chronic diseases such as diabetes, cardiovascular dis-
eases (particularly heart disease and stroke), and cancer
are among the most prevalent and costly of all health prob-
lems (3-6). More than 90 million Americans live with
chronic diseases (3), and chronic diseases account for three
fourths of the nation’s $1.4 trillion in medical care costs
and one third of the years of potential life lost before age 65
(3). Individual, family, health system, community, and
societal factors are all believed to have contributed to the
rise in chronic disease rates in the United States (7).
Factors postulated to explain this phenomenon range from
increased prevalence of individual risk factors (8), a lack of
health care resources for the poor and underserved (9), and
environmental conditions that do not support the adoption
and sustainability of healthy eating and physical activity
behavior (10). Collectively, these factors may express
themselves differently from one sociogeographical context
to another. As a result, a combination of tailored, multifac-
eted, and multidisciplinary clinical and public health
approaches is needed to systematically intervene.
More recent public health discussions about the role of
social determinants and health disparities among women
and racial and ethnic minorities in the United States help
illustrate the complex and dynamic aspects of chronic dis-
eases. The discussions also emphasize the dynamic inter-
actions between individuals and their social and physical
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environments (11). Addressing the reciprocal relationship
between the individual and the environment requires com-
plementary clinical and public health approaches as well as
the unique contributions of numerous partners (2). Clearly,
reducing the burden of chronic diseases requires amassing
and coordinating efforts from various traditional public
health partners as well as other untapped resources that
share an interest in preventing chronic diseases and
improving the quality of life of people with chronic diseases.
The Centers for Disease Control and
Prevention
The Centers for Disease Control and Prevention (CDC) is
dedicated to helping Americans live long, healthy, and 
satisfying lives (12). The organization’s missions include
preventing death and disability from chronic diseases; 
promoting maternal, infant, and adolescent health; and
promoting healthy personal behaviors. To accomplish these
missions, the CDC relies on the strengths and contributions
of a diverse group of committed partners such as state and
local health departments, international and national organ-
izations, academic institutions, philanthropic foundations,
industry and labor groups, professional associations, and
volunteer and community organizations (12).
Through its relationship with collaborating partners, the
CDC is able to provide national leadership in health pro-
motion and disease prevention by 1) conducting public
health surveillance, epidemiologic studies, and behavioral
interventions; 2) disseminating guidelines and recommen-
dations for public health interventions; and 3) helping
state health departments build their capacity to prevent
chronic diseases (12). The CDC is committed to applying
research findings to chronic disease prevention and control
to improve the health of the people in the United States. To
accomplish this goal, the CDC is developing, implement-
ing, and evaluating national, regional, state, and commu-
nity programs. During this process, the CDC considers the
distribution of risk factors among vulnerable populations,
social determinants of health, and characteristics of the
social and physical environments.
Program Evaluation: Demand for
Accountability and Results
Evaluation of national, regional, state, and community
programs remains a priority of the CDC, which uses vari-
ous tailored program evaluation activities designed to
meet their stakeholders’ needs and capacities. In addition,
demand is increasing for 1) a formal evaluation infrastruc-
ture for regularly assessing the effectiveness of public
health programs (13); 2) the creation and maintenance of
evaluation monitoring systems to collect, analyze, and
interpret public health intervention findings (13,14); 3) the
capacity to monitor progress toward improving the health
of vulnerable populations (15,16); and 4) evidence that
findings about changes in health outcomes (whether posi-
tive or negative) are used to make changes in programs
(17,18). Using program evaluation activities that incorpo-
rate all four of these important factors will better position
the CDC and its partners to make critical decisions about
program performance and the use of federal funds in a way
that demonstrates sound stewardship of taxpayer money.
The demand for accountability is not new to the CDC. In
2002, Milstein et al explained:
With demands for accountability and results at a high
level, the CDC faced the problem that many of its pro-
grams involved collaborative, multifaceted initiatives
with communities across the nation and around the
world. Engaging these community partners required
complex approaches melding policy, structural, and
individual change that were 1) implemented different-
ly in different contexts and 2) hard to measure feasibly
and consistently. Furthermore, the ultimate outcomes
of interest, such as reductions in hypertension, HIV
infection, obesity, or violence, were ones that might
take years to materialize. The CDC remained commit-
ted to showing that its efforts as an agency were
worthwhile. Yet understanding the precise effects of a
single program under these circumstances proved to
be an extraordinary challenge. (13)
Fortunately, considerable development in program eval-
uation approaches in the last century has made it possible
to embrace the complexities of public health (19). For
example, decision and accountability, utilizations focused,
client centered and responsive, case study, and outcomes
monitoring and value added are a few of the evaluation
approaches that have met the high program evaluation
standards of usability, feasibility, propriety, and accuracy
(19). Because of the need for multifaceted, multidiscipli-
nary, and multidimensional approaches to address real-
world factors that influence chronic diseases, the use of one
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effectiveness is imperative.
Program Evaluation and Chronic Diseases
Gathering evidence to demonstrate accountability for
program outcomes is a priority for the CDC. Evaluation is
one of the 10 essential public health services and is con-
sidered a critical function of public health agencies (2). The
articles in this program evaluation issue of PCD include
Original Research, Community Case Studies, Essays,
Step-by-Step, Tools & Techniques, and Book Reviews.
Through these various types of articles, we hope to expose
readers to the value of stakeholder participation at all lev-
els of program design; share a rich discussion of how pro-
gram evaluation findings can and should be used to make
improvements in the implementation and evaluation of
existing and future chronic disease programs; promote the
identification of program evaluation areas that need addi-
tional attention and improvements; and explore examples
of evaluation methods and approaches.
Original Research
In Mukhtar et al’s original research article on Healthy
People 2010 diabetes objectives (20), evaluators describe
the way the CDC’s Division of Diabetes Translation (DDT)
adopted and monitored progress toward selected Healthy
People 2010 objectives. These objectives included improv-
ing the rates of preventive care service, such as hemoglo-
bin A1c tests and annual foot and eye examinations,
among people with diabetes. Data from the Behavioral
Risk Factor Surveillance System (BRFSS) diabetes module
were used to evaluate progress toward achieving Healthy
People 2010 targets. Evaluators compared 2003 data with
Healthy People 2010 targets and 2000 baseline rates. The
degree to which the DDT and its partners achieved the
Healthy People 2010 targets is discussed, as are challenges
and important factors to consider when selecting and mon-
itoring these national objectives. Areas for future research
and evaluation are also discussed.
In their original research article, Besculides et al
describe an evaluation approach that identifies best prac-
tices in implementing lifestyle interventions for women in
the WISEWOMAN program (21). The authors report using
qualitative and quantitative methods, or a mixed-method
approach, in this evaluation effort. Specifically, they use
quantitative program performance data to identify high-
and low-performance WISEWOMAN sites and use quali-
tative interviews, observations, and focus groups to
understand underlying strategies for implementing the
interventions. The authors conclude with a discussion
about the relevance of using a mixed-method approach to
conduct evaluation of community-based interventions.
Hypertension is the leading cause of stroke, coronary
artery disease, heart attacks, and heart and kidney failure
in the United States (22). Programs that provide free or
low-cost blood pressure medications and preventive treat-
ment protocols based on authoritative guidelines may not
only improve health among patients with hypertension but
also result in substantial cost savings. Rein et al found that
the state-funded education and direct service program in
Georgia resulted in better health outcomes than two other
scenarios — no preventive treatment for high blood pres-
sure and the average U.S. private sector preventive treat-
ment (23). Evaluators conclude with a discussion about the
need for more evidence-based and cost-effective programs
to prevent heart disease and stroke.
Community Case Studies
In Houston et al’s community case study, the authors
share with readers the evaluation of South Carolina’s
Diabetes Prevention and Control Program and the
Diabetes Today Advisory Council’s effort to conduct a 
1-day conference for people with diabetes. The conference
offered educational sessions on improving diabetes 
self-management practices (24). Authors describe the
evaluation efforts since the conference’s inception and
report results from data gathered using qualitative and
quantitative evaluation methods. Of importance is a dis-
cussion of the evolution of the evaluation planning and
methodology as the conference became more sophisticat-
ed and far-reaching over a period of years. Using focus
groups, a general participant questionnaire, and a
Diabetes-Related Understanding Scale, evaluators were
able to determine that participants were motivated to
adopt diabetes self-management behavioral changes and
were pleased with the conference overall. The evaluation
also demonstrated that the conference effectively
improved diabetes management skills among attendees.
Evaluators concluded that the conference could help sup-
plement and reinforce formal diabetes education.
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Ideally, program evaluation should be considered at the
inception of any public health program. Balamurugan et al
explain that the effectiveness of programs in underserved
rural areas of Arkansas was impeded because of the lack of
advance evaluation planning (25). The authors report that
the state health department was successful in establishing
12 diabetes self-management education (DSME) programs
in underserved counties that had a disproportionately high
prevalence of diabetes. Although some of the barriers faced
by the programs were anticipated (e.g., staffing and reim-
bursement issues), the authors discuss the reasons only
some of those barriers could be addressed effectively.
Unanticipated barriers were encountered as well, such as
inconsistent data collection procedures, a suboptimal data
collection capacity, participant retention issues, and the
lack of an adopted and implemented evaluation plan
among DSME program sites. The authors offer strategies
to overcome barriers and use what they learned to plan the
new wave of DSME sites that will soon be initiated in sim-
ilar geographical regions of Arkansas.
Step-by-Step
In 1999, the CDC published the Framework for Program
Evaluation in Public Health (26). Martin and Heath use
this framework to discuss a hypothetical case study of a
physical activity program to prevent diabetes. In their arti-
cle, the authors discuss each of the six steps: 1) engage
stakeholders, 2) describe the program, 3) focus the evalua-
tion design, 4) gather credible evidence, 5) justify conclu-
sions, and 6) ensure use and share lessons learned (27).
The authors describe stakeholders and present a logic
model with possible short-term, intermediate, and long-
term objectives. They briefly discuss quantitative and
qualitative data gathering and analysis and conclude with
a brief discussion about the ways to share program evalu-
ation findings with the community.
Essays
An essay by Martin and Thomas addresses Office of
Management and Budget (OMB) clearance (28). Federally
funded program evaluations usually require collecting
data from the public. The data are used to measure
processes, impact, and outcomes resulting from health pro-
motion programming. Although collecting these data is
important, so is considering the burden of paperwork on
the public. Martin and Thomas discuss the process for
attaining approval from the OMB for federally sponsored
data collection. They also describe how important it is for
program evaluators and their collaborators and partners
working with the federal government to plan early and
consider OMB clearance requirements.
Tools & Techniques
The  Steps to a HealthierUS Cooperative Agreement
Program (i.e., the Steps Program) focuses on chronic dis-
ease prevention and health promotion efforts to reduce the
burden of diabetes, obesity, asthma, and related risk fac-
tors. In their article, MacDonald et al describe the need for
the Steps Program to coordinate national and community
evaluation efforts (29). The authors discuss the importance
of providing national leadership for evaluation among all
Steps Program sites while also allowing flexibility for site-
specific evaluation efforts that would allow movement
toward well-designed and complementary evaluation
plans at national and community levels.
Mukhtar et al (30) describe their experience in develop-
ing the Diabetes Indicators and Data Sources Internet
Tool (DIDIT). This user-friendly Web-based tool contains
information on 38 diabetes indicators and their associated
data sources. The DIDIT was developed in collaboration
with multiple stakeholders, including state representa-
tives, the CDC, and contractors. The authors highlight the
elements that were essential for the tool’s development.
Expertise in diabetes surveillance and software develop-
ment as well as stakeholder enthusiasm and dedication
were important components. These components were com-
plemented by the project leader’s strong leadership skills
and sense of vision, clear communication and collaboration
among all team members, and commitment from the man-
agement of the Division of Diabetes Translation.
In their article, Tucker et al begin with a brief history of
the Racial and Ethnic Approaches to Community Health
(REACH 2010) initiative (31). Authors discuss the way 40
REACH 2010 communities (African American, Alaska
Native, American Indian, Asian American, Hispanic, and
Pacific Islander communities) use community-based par-
ticipatory approaches to reduce risk factors for and the
prevalence of chronic diseases. Using a logic model, the
authors describe the way program activities are related to
program theory as well as short- and long-term program
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local, site-specific evaluations as well as a national evalua-
tion that takes into consideration cross-site assessment of
successful partnerships. The authors discuss the way using
qualitative data collected from REACH 2010 projects with
a management information system called the REACH
Information Network will help users understand how pro-
gram components influence system changes. The authors
also describe the way quantitative data are systematically
collected using the REACH Risk Factor Survey to establish
estimates of program effects. Local, site-specific, and
national evaluations using qualitative and quantitative
evaluation methods will help determine whether local
interventions decrease health disparities.
Book Review
This issue includes Lavinghouze’s book review (32) of
Practical Program Evaluation Assessing and Improving
Planning, Implementation, and Effectiveness by Huey-
Tsyh Chen (33). Lavinghouze describes Chen’s efforts to
provide a program evaluation taxonomy that would be par-
ticularly useful to individuals new to the field of program
evaluation as well as to more seasoned evaluators who
want to encourage stakeholder understanding of evalua-
tion. She describes Chen’s ability to provide a thorough
overview and review of the theory-driven approach to eval-
uation and apply it to the taxonomy he presents. She
points out that although terms and definitions used in the
book are inconsistent with those found in current litera-
ture, Chen encourages the readers to broaden their per-
spectives so that they can embrace this new terminology.
According to Lavinghouze, Chen’s book emphasizes
acknowledging the stakeholder throughout the evaluation
process. She concludes that Chen’s taxonomy is a major
step in the overall conceptualization of the evaluation
process and that the taxonomy enhances evaluators’
attempts to understand and appropriately apply evalua-
tion designs at a practical program level.
Conclusion
The diverse nature of evaluation efforts undertaken by
the CDC and its many partners highlights the interest and
commitment to designing, implementing, and evaluating
high-quality chronic disease prevention and control activi-
ties that are responsive to target audience and stakehold-
er needs. The use of evaluation is being integrated into the
accountability movement and is embedded in a consumer-
oriented public health ideology (34). It is becoming an
increasingly important accountability tool in the current
environment and is considered a necessary component of
decision making about the use of federal funds to support
successful programs. According to Segerholm, “Against
this background, it is high time to start critically examin-
ing evaluation itself as a phenomenon and practice” (34).
We hope the articles in this issue not only emphasize the
importance of program evaluation but also provide our
readers with examples to incorporate into evaluation
approaches, stakeholder engagement strategies, and their
own public health efforts.
Author Information
Corresponding Author: Leonard Jack, Jr, PhD, Applied
Behavioral Research, Epidemiology, Surveillance, and
Evaluation (ABRESE) Team, Program Development
Branch, Division of Diabetes Translation (DDT), National
Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC), 4770 Buford Hwy, NE, Mail Stop K-10,
Atlanta, GA 30341 Telephone: 770-488-5942. E-mail:
LJack@cdc.gov. Dr. Jack is also affiliated with Louisiana
State University Health Sciences Center School of Public
Health, Behavioral and Community Health Sciences
Program, New Orleans, La.
Author Affiliations: Qaiser Mukhtar, PhD,
Epidemiologist, Maurice Martin, PhD, Evaluation and
Research Scientist, Mark Rivera, PhD, Evaluation and
Research Scientist, ABRESE Team, Program
Development Branch, DDT, NCCDPHP, CDC, Atlanta,
Ga; Rene Lavinghouze, MA, Health Scientist, Program
Services Team, Division of Oral Health, NCCDPHP, CDC,
Atlanta, Ga; Jan Jernigan, PhD, Evaluation Specialist,
Cardiovascular Health Branch, NCCDPHP, CDC, Atlanta,
Ga; Paul Z. Siegel, MD, MPH, Research Chemist,
Community Health and Program Services Branch,
Division of Adult and Community Health, NCCDPHP,
CDC, Atlanta, Ga; Gregory Heath, PhD, Team Lead,
Program Branch, Division of Nutrition and Physical
Activity, NCCDPHP, CDC, Atlanta, Ga; Dara Murphy,
Branch Chief, Program Development Branch, DDT,
NCCDPHP, CDC, Atlanta, Ga.
VOLUME 3: NO. 1
JANUARY 2006
www.cdc.gov/pcd/issues/2006/jan/05_0141.htm • Centers for Disease Control and Prevention 5
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.VOLUME 3: NO. 1
JANUARY 2006
References
1. U.S. Department of Health and Human Services.
Healthy People 2010: understanding and improving
health. 2nd ed. Washington (DC): U.S. Government
Printing Office; 2000 Nov.
2. Nelson JC, Essien, Essien JDK, Loudermilk R, Cohen
D. The public health competency handbook: optimizing
individual and organizational performance for the
public’s health. Atlanta (GA): Center for Public Health
Practice of the Rollins School of Public Health; 2002.
3. Chronic Disease Prevention [Internet]. Atlanta (GA):
U.S. Department of Health and Human Services,
Centers for Disease Control and Prevention, National
Center for Chronic Disease Prevention and Health
Promotion;2005 [cited 2005 June 19]. Available from:
URL: http://www.cdc.gov/nccdphp/.
4. National Center for Health Statistics. Health, United
States, 2004 with chartbook on trends in the health of
Americans. Hyattsville (MD): U.S. Department of
Health and Human Services, Centers for Disease
Control and Prevention, National Center for Health
Statistics;2004 [cited 2005 July 11]. Available from:
URL: http://www.cdc.gov/nchs/data/hus/hus04.pdf.
5. Centers for Disease Control and Prevention. Regional
and racial differences in prevalence of stroke—23
states and District of Columbia, 2003. MMWR
2005;54(19):481–4.
6. Centers for Disease Control and Prevention.
Racial/Ethnic and socioeconomic disparities in multi-
ple risk factors for heart disease and stroke—United
States, 2003. MMWR 2005;54(05):113-7.
7. American Association of Public Health. Effective inter-
ventions for reducing racial and ethnic disparities in
health. Am J Public Health 2001 Mar;91(3):485-6.
8. Rose G. Sick individuals and sick populations. Int J
Epidemiol 1985 Mar;14(1):32-8.
9. Litaker D, Koroukian SM, Love TE. Context and
healthcare access: looking beyond the individual. Med
Care 2005 June;43(6):531-40.
10. Ewing R. Building environment to promote health. J
Epidemiol Community Health 2005 July;59(7):536-7.
11. Jack L Jr, Liburd L, Spencer T, Airhihenbuwa CO.
Understanding the environmental issues in diabetes
self-management education research: a reexamination
of 8 studies in community-based settings. Ann Intern
Med 2004 Jun;140(11):964-71.
12. About CDC’s Chronic Disease Center [Internet].
Atlanta (GA): U.S. Department of Health and Human
Services, Centers for Disease Control and Prevention,
National Center for Chronic Disease Prevention and
Health Promotion;2004 [cited 2005 June 19]. Available
from: URL: http://www.cdc.gov/nccdphp/about.htm.
13. Milstein B, Chapel T, Wetterhall SF, Cotton DA.
Building capacity for program evaluation at the
Centers for Disease Control and Prevention. New
Directions for Evaluation 2002;93:27-46.
14. Newcomer K. Tracking and probing program perform-
ance: fruitful path or blind alley for evaluation profes-
sionals. American Journal of Evaluation
2001;22(3):337-41.
15. Keppel KG, Pearcy JN, Klein RJ. Measuring progress
in Healthy People 2010. Healthy People 2010
Statistical Notes 2004 Sept;(25):1-16.
16. Desai J, Geiss L, Mukhtar Q, Harwell T, Benjamin S,
Bell R. Public health surveillance of diabetes in the
United States. J Public Health Manag Pract 2003
Nov;Suppl:S44-51.
17. Newcomer KE. Using performance measurement to
improve public and nonprofit programs. New
Directions for Evaluation 1997;75:5-14.
18. House ER. Evaluation in the government market-
place. Eval Pract 1997;18(1):37-48.
19. Stufflebeam DL. Evaluation Models. New Directions
for Evaluation 2001;89:8-98.
20. Mukhtar Q, Jack L Jr, Murphy D, Martin, M, Rivera
MD. Evaluating progress toward Healthy People 2010
national diabetes objectives. Prev Chronic Dis [serial
online] 2006 Jan.
21. Besculides M, Hesketh H, Farris R, Will J. Identifying
best practices for WISEWOMAN programs using a
mixed-methods evaluation. Prev Chronic Dis [serial
online] 2006 Jan.
22. Hajjar I, Kotchen TA. Trends in prevalence, aware-
ness, treatment and control of hypertension in the
United States, 1988-2000. JAMA 2003 Jul;290(2):199-
206.
23. Rein D, Orenstein RC, Chen H, Jones P, Brownstein
N, Farris R. A cost evaluation of the Georgia Stroke
and Heart Attack Prevention Program. Prev Chronic
Dis [serial online] 2006 Jan.
24. Houston J, Williams J, Martin M, Hill R. The Annual
African American Conference on Diabetes: evolving
program evaluation with evolving program implemen-
tation. Prev Chronic Dis [serial online] 2006 Jan.
25. Balamurugan A, Rivera M, Jack L Jr, Allen K, Morris
S. Barriers to diabetes self-management education
programs in underserved rural Arkansas: implications
6 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/jan/05_0141.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.for program evaluation. Prev Chronic Dis [serial
online] 2006 Jan.
26. Centers for Disease Control and Prevention.
Framework for program evaluation in public health.
MMWR 1999;48(RR-11):1-40.
27. Martin S, Heath G. A six-step model for evaluation of
community-based physical activity programs. Prev
Chronic Dis [serial online] 2006 Jan.
28. Martin M, Thomas D. Using the Office of Management
and Budget (OMB) clearance process in program plan-
ning and evaluation. Prev Chronic Dis [serial online]
2006 Jan.
29. MacDonald G, Garcia D, Zaza S, Schooley M, Compton
D, Bryant T, et al. Steps to a HealthierUS Cooperative
Agreement Program: foundational elements for pro-
gram evaluation planning, implementation, and use of
findings. Prev Chronic Dis [serial online] 2006 Jan.
30. Mukhtar Q, Mehta P, Brody ER, Camponeschi J,
Friedrichs M, Kemple AM, et al. Development of the
Diabetes Indicators and Data Sources Internet Tool
(DIDIT). Prev Chronic Dis [serial online] 2006 Jan.
31. Tucker P, Liao Y, Giles WH, Liburd L. The REACH
2010 logic model: An illustration of expected perform-
ance. Prev Chronic Dis [serial online] 2006 Jan.
32. Lavinghouze SR. Practical program evaluation:
assessing and improving planning, implementation,
and effectiveness [book review]. Prev Chronic Dis [seri-
al online] 2006 Jan.
33. Huey-Tsyh C. Practical program evaluation: assessing
and improving planning, implementation, and effec-
tiveness. Thousand Oaks (CA): SAGE Publications
Inc; 2004.
34. Segerholm C. Researching evaluation in national
(state) politics and administration: a critical approach.
American Journal of Evaluation 2003;24(3):353-72.
VOLUME 3: NO. 1
JANUARY 2006
www.cdc.gov/pcd/issues/2006/jan/05_0141.htm • Centers for Disease Control and Prevention 7
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.